ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,102,000 | -89.5% | 6,405 | -92.3% | 0.00% | -90.9% |
| Q2 2021 | $10,467,000 | -50.8% | 83,412 | -46.8% | 0.01% | -57.7% |
| Q1 2021 | $21,258,000 | -6.3% | 156,761 | -11.6% | 0.03% | -13.3% |
| Q4 2020 | $22,684,000 | +5.0% | 177,304 | -7.7% | 0.03% | -14.3% |
| Q3 2020 | $21,611,000 | +452.4% | 192,043 | +367.7% | 0.04% | +400.0% |
| Q2 2020 | $3,912,000 | -0.5% | 41,061 | -6.1% | 0.01% | -22.2% |
| Q1 2020 | $3,931,000 | +816.3% | 43,736 | +440.9% | 0.01% | +800.0% |
| Q4 2019 | $429,000 | -43.3% | 8,086 | -50.2% | 0.00% | -50.0% |
| Q1 2019 | $756,000 | -48.5% | 16,238 | -51.8% | 0.00% | -33.3% |
| Q4 2018 | $1,467,000 | -43.2% | 33,683 | -25.4% | 0.00% | -40.0% |
| Q3 2018 | $2,583,000 | +104.2% | 45,128 | +39.5% | 0.01% | +66.7% |
| Q1 2018 | $1,265,000 | +96.4% | 32,354 | +113.2% | 0.00% | +50.0% |
| Q4 2017 | $644,000 | -47.7% | 15,178 | -68.5% | 0.00% | -50.0% |
| Q4 2016 | $1,231,000 | +7.9% | 48,251 | +53.0% | 0.00% | +33.3% |
| Q3 2016 | $1,141,000 | – | 31,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |